Acquisitions (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Mar. 07, 2016
Stock Issued During Period, Value, New Issues			$ 668,437
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	$ (3,823,281)	$ (1,541,353)	(6,265,714)	$ (4,342,439)
Jade Therapeutics, Inc [Member]
Business Acquisition, Percentage of Voting Interests Acquired					100.00%
Business Combination, Consideration Transferred, Liabilities Incurred			$ 300,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			765,728
Percentage Of Common Stock Issued			90.00%
Percentage Of Common Stock To Be Issued			10.00%
Business Combination, Contingent Consideration, Liability	$ 2,164,451		$ 2,164,451
Stock Issued During Period, Value, New Issues			$ 2,910,000
Business Acquisition, Share Price	$ 3.80		$ 3.80
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$ 186,000		$ 186,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets	369,000		369,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total			$ 118,000
Finite-Lived Intangible Asset, Useful Life			3 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables	$ 46,000		$ 46,000
Jade Therapeutics, Inc [Member] | Selling, General and Administrative Expenses [Member]
Business Combination, Acquisition Related Costs			$ 234,000